🔴 Chemours is trading 5.5% down today as U.S. stocks sell off

Chemours is trading at $13.03, down 5.51%, as U.S. stocks and materials shares fell sharply on November 5.

• Class-action reminders about alleged Opteon demand misstatements circulated November 4–5, adding legal overhang; available coverage does not establish them as the direct cause of the intraday move.
• Recent Q3 results included $0.21 adjusted EPS, below estimates, and a weaker sequential outlook for parts of the business. Shares had risen 5.35% on November 4.